European Archives - Page 339 of 1110 - European Medical Journal

Current and Upcoming Treatment Strategies After CDK4/6 Inhibitors for Patients With ER+/HER2- Advanced Breast Cancer

The latest recommendations and upcoming treatment strategies for patients with oestrogen-receptor positive (ER+), human epidermal growth…

Reduced Diversity of HLA Class I Alleles May Contribute to the Early Manifestation of Breast Cancer in Carriers of the BRCA1 Mutation

Most female carriers of germline BRCA1 mutations develop breast and/or ovarian cancer. However, the penetrance of BRCA1 pathogenic variants…

The Hallmarks of Cancer in 2023

CURRENT cancer hallmarks, their capabilities, and potential targeted therapies were the focus of the presentation given by Douglas Hanahan…

Precision Medicine-Based Platform to Guide the Treatment of EML4-ALK Lung Cancers and Other Non-Small Cell Lung Cancers

Lung cancer (LC) remains the top cause of cancer-associated mortality worldwide, with a 10-year overall survival rate of only 5%.1…

Isolated Tumour Cells in Early Endometrial Carcinomas

Endometrial cancer is the most common gynaecologic malignancy in high-income countries due to increased life expectancy. Approximately…

Programmed Death-Ligand 1 Expression and its Relation to EML4-ALK Gene Variants in Metastatic Lung Adenocarcinoma: A Single Centre Real-World Experience

Targeted therapy and immunotherapy have revolutionised the treatment of metastatic non-small cell lung cancer, particularly adenocarcinoma…

ESMO 2023 Abstract Highlights

FOR the first time, there is an alternative to chemotherapy for patients with advanced or metastatic urothelial carcinoma. The results of a…

Improving Inclusivity and Diversity in Clinical Trials

Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…

Dostarlimab and Radiotherapy in A Patient with MSI-H/dMMR Endometrial Cancer

Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…

Spotlight: November 2023

GOLD looks back at some of the top pharma news stories of the past month including new appointments, regulatory wins and surprising survey results.